Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Hormone therapy for menopause may help women sleep better

NCT ID NCT07674316

Symptom relief Sponsor: Insel Gruppe AG, University Hospital Bern Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time

Summary

This study investigates whether menopausal hormone therapy (MHT) can improve sleep quality in women going through menopause. Researchers will compare sleep in women who receive MHT to those who do not, using questionnaires and sleep diaries. The goal is to see if MHT can help with common sleep problems during menopause.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
menopausal hormone therapy (MHT)
What this could lead to
If it works, this could provide evidence that MHT improves sleep quality and quality of life for women going through menopause.
What could go wrong
This is a relatively small, unblinded trial, so results may be influenced by participant expectations. MHT also carries known risks, such as blood clots and certain cancers.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 172 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2025

Expected to finish

Aug 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Healthy peri- and postemenopausal women with an indication for HRT

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Informed Consent as documented by signature * Peri- and postmenopausal woman * Indication for MHT (e.g. climacteric syndrome, osteoporosis, etc.) * Age ≥ 18 years * German Speaking Exclusion Criteria: * Obesity BMI ≥ 30 kg/m² * Pregnancy or Lactation * Status post Hysterectomy * Systemic hormone therapy or hormonal contraception (estrogens, progestogens, androgens) during the study and within 12 weeks prior to study entry * Prescribed medication for therapy of sleep problems 12 weeks prior to study entry (excluding phytotherapeutic agents and over the counter medication) * Medication that could distort sleep (e.g. antidepressant, anticonvulsant and antipsychotic medications) * Substance abuse (e.g. daily alcohol consumption, drugs in general) * Contraindication for menopausal hormone therapy according to swissmedicinfo.ch * Neoplasia of the breast or other sexual organ * Benign or malignant liver tumors * Acute or chronic liver disease * Cholestatic jaundice * Porphyria * Arterial or venous thromboembolic events * Abnormal genital bleeding of unknown cause * Known or suspected non-compliance due to inability to follow the procedures of the study (e.g. illiteracy, language problems, psychological disorders, dementia, etc.)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Menopause are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

insomnia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Menopause Psychological wellbeing Sleep quality

Contacts and locations

Locations

  • Inselspital Bern, Frauenklinik

    Bern, 3010, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.